Matt talks to Doug Clinton from Loop Ventures in their Neurotech Podcast Episode 10.
Dr. Matt Angle is the CEO and founder of Paradromics, a brain-computer interface company developing high-bandwidth implantable neural interfaces. Matt completed his B.S. in Biology at Carnegie Melon University and his Ph.D. in Neuroscience at the Max Planck Institute.
Top 3 Takeaways
- Paradromics is working on high-density microwire electrode arrays because they’re advantageous in a number of ways as compared to alternative types of invasive neural interfaces.
- The technology under development by Paradromics will first be used by researchers to ask and answer basic neuroscience questions, and then will help treat locked-in patients pending further development and FDA approval.
- Considerations about neural data privacy are similar to considerations about data privacy in general.